These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31552183)

  • 1. Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma.
    Kim SH; Park B; Hwang EC; Hong SH; Jeong CW; Kwak C; Byun SS; Chung J
    Front Oncol; 2019; 9():859. PubMed ID: 31552183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of pathologic nodal positivity in non-metastatic patients with renal cell carcinoma who underwent radical or partial nephrectomy.
    Kim SH; Park B; Hwang EC; Hong SH; Jeong CW; Kwak C; Byun SS; Chung J
    Sci Rep; 2021 Feb; 11(1):3079. PubMed ID: 33542395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Retrospective, Multicenter, Long-Term Follow-Up Analysis of the Prognostic Characteristics of Recurring Non-Metastatic Renal Cell Carcinoma After Partial or Radical Nephrectomy.
    Kim SH; Park B; Hwang EC; Hong SH; Jeong CW; Kwak C; Byun SS; Chung J
    Front Oncol; 2021; 11():653002. PubMed ID: 34262859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review and meta-analysis of clinicopathologic factors linked to oncologic outcomes for renal cell carcinoma with tumor thrombus treated by radical nephrectomy with thrombectomy.
    Gu L; Li H; Wang Z; Wang B; Huang Q; Lyu X; Shen D; Gao Y; Fan Y; Li X; Xie Y; Du S; Liu K; Tang L; Peng C; Ma X; Zhang X
    Cancer Treat Rev; 2018 Sep; 69():112-120. PubMed ID: 29960124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
    Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M;
    BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data.
    Erdem S; Bertolo R; Campi R; Capitanio U; Amparore D; Anceschi U; Mir MC; Roussel E; Pavan N; Carbonara U; Kara O; Klatte T; Marchioni M; Pecoraro A; Muselaers S; Marandino L; Diana P; Borregales L; Palumbo C; Warren H; Wu Z; Calio A; Ciccarese C; Degirmenci E; Aydin R; Rebez G; Schips L; Simone G; Minervini A; Serni S; Ozcan F
    Urol Oncol; 2024 May; 42(5):163.e1-163.e13. PubMed ID: 38443238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of modified Glasgow Prognostic Score in patients with non-metastatic clear cell renal cell carcinoma.
    Cho DS; Kim SI; Choo SH; Jang SH; Ahn HS; Kim SJ
    Scand J Urol; 2016 Jun; 50(3):186-91. PubMed ID: 26878156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of sex on the prognostic value of body mass index in non-metastasis renal cell carcinoma.
    Zheng Y; Bao L; Chen J; Pan Y; Wang Q; Chen L; Gao X
    Cancer Manag Res; 2019; 11():3869-3886. PubMed ID: 31118803
    [No Abstract]   [Full Text] [Related]  

  • 10. Recurrence pattern in patients with locally advanced renal cell carcinoma: The implications of clinicopathological variables.
    Sameh WM; Hashad MM; Eid AA; Abou Yousif TA; Atta MA
    Arab J Urol; 2012 Jun; 10(2):131-7. PubMed ID: 26558015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factor for Korean patients with renal cell carcinoma and venous tumor thrombus extension: application of the new 2009 TNM staging system.
    Cho MC; Kim JK; Moon KC; Kim HH; Kwak C
    Int Braz J Urol; 2013; 39(3):353-63. PubMed ID: 23849567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival And Progression After Radical Nephrectomy In A Cohort Of Non-Metastatic Renal Cell Carcinoma Treated With Curative Intent.
    Khan N; Irshad Khalil MA; Ali A; Manzoor S; Urooj N; Mir K
    J Ayub Med Coll Abbottabad; 2019; 31(3):314-319. PubMed ID: 31535497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic Outcomes of Cytoreductive Nephrectomy in Synchronous Metastatic Renal-Cell Carcinoma: A Single-Center Experience.
    Choi CI; Kang M; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Seo SIL
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1189-e1199. PubMed ID: 30262447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the long-term follow-up and perioperative outcomes of partial nephrectomy and radical nephrectomy for 4 cm to 7 cm renal cell carcinoma: a systematic review and meta-analysis.
    Jiang YL; Peng CX; Wang HZ; Qian LJ
    BMC Urol; 2019 Jun; 19(1):48. PubMed ID: 31174522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of tumor size on patient survival after radical nephrectomy for pathological T3a renal cell carcinoma.
    Sugiyama Y; Yatsuda J; Murakami Y; Ito N; Yamasaki T; Mikami Y; Ogawa O; Kamba T
    Jpn J Clin Oncol; 2019 May; 49(5):465-472. PubMed ID: 30793163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of curative nephrectomy against renal cell carcinoma based on a central pathological review of 914 specimens from the era of cytokine treatment.
    Ito N; Kojima S; Teramukai S; Mikami Y; Ogawa O; Kamba T
    Int J Clin Oncol; 2015 Dec; 20(6):1161-70. PubMed ID: 25981949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival.
    Colin P; Ouzzane A; Yates DR; Audenet F; Pignot G; Arvin-Berod A; Merigot de Treigny O; Laurent G; Valeri A; Irani J; Saint F; Gardic S; Gres P; Rozet F; Neuzillet Y; Ruffion A; Rouprêt M
    Ann Surg Oncol; 2012 Oct; 19(11):3613-20. PubMed ID: 22843187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes.
    Albisinni S; Pretot D; Al Hajj Obeid W; Aoun F; Quackels T; Peltier A; Roumeguère T
    Prog Urol; 2019; 29(8-9):423-431. PubMed ID: 31196826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
    Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncologic Outcomes of Renal Cell Carcinoma Patients Undergoing Radical Nephrectomy and Venous Thrombectomy: Prospective Follow-Up from a Single Center.
    Zhang Y; Tian X; Bi H; Hong P; Liu Z; Yan Y; Liu C; Ma L
    J Oncol; 2022; 2022():9191659. PubMed ID: 35342403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.